It’s only a matter of time before DePuy Synthes is spun off for pennies. The low growth in the segment no longer offsets the high margin business orthopedics once was. The JNJ compliance organization was developed for pharma and specialty devices to be mass produced and do not serve “widget businesses”. It’s particularly pathetic to see so many good people being hung out to dry because of their “golden handcuffs”, “vesting schedules”, and other monetary traps which will never pay out. Or maybe they are stuck at jnj medtech because they realize they have no marketable skills and are generously paid for doing nothing. That is certainly the case at HQ with the revolving door of dogshit never weres talking about a new era. LOL
